Undesired Effect of Vancomycin Prolonged Treatment: Enhanced Biofilm Production of the Nosocomial Pathogen Candida auris

Fungal infections are often consequent to prolonged antibiotic treatments. Vancomycin (Van) is the first-choice antibiotic in the treatment of Staphylococcus aureus infections associated with colonization of catheter surfaces. We demonstrate the direct effect of Van in promoting the formation of the biofilm of the emergent yeast pathogen Candida auris, developed in the conventional polystyrene microwell plate model, as well as on silicone surfaces (22 and 28% increase in total biomass, respectively) and on an S. aures biofilm, residual after vancomycin treatment, where C. auris achieved 99% of the mixed biofilm population. The effect of Van was assessed also in vivo, in the Galleria mellonella infection model, which showed higher mortality when infected with the yeast pathogen in the presence of the antibiotic. This evidence enhances awareness of the potential risk associated with prolonged antibiotic use in promoting fungal infections.

[1]  Rita P. Ribeiro,et al.  Essential Oils as a Good Weapon against Drug-Resistant Candida auris , 2022, Antibiotics.

[2]  M. Guida,et al.  Activity of Free and Liposome-Encapsulated Essential Oil from Lavandula angustifolia against Persister-Derived Biofilm of Candida auris , 2021, Antibiotics.

[3]  D. Castelo-Branco,et al.  Trichosporon asahii and Trichosporon inkin Biofilms Produce Antifungal-Tolerant Persister Cells , 2021, Frontiers in Cellular and Infection Microbiology.

[4]  M. Billamboz,et al.  Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris , 2021, Microorganisms.

[5]  Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer , 2021, Advances in Medical Technologies and Clinical Practice.

[6]  J. Osatnik,et al.  [Epidemiological analysis of catheter-related bloodstream infections in medical-surgical intensive care units]. , 2021, Medicina.

[7]  A. Tsakris,et al.  Central venous catheter-related bloodstream infection and colonization: the impact of insertion site and distribution of multidrug-resistant pathogens , 2020, Antimicrobial Resistance & Infection Control.

[8]  A. Macêdo,et al.  Alternative method in Galleria mellonella larvae to study biofilm infection and treatment. , 2019, Microbial pathogenesis.

[9]  F. Groppo,et al.  Fusogenic Liposomes Increase the Antimicrobial Activity of Vancomycin Against Staphylococcus aureus Biofilm , 2019, Front. Pharmacol..

[10]  A. Fife,et al.  Candida auris outbreak: Mortality, interventions and cost of sustaining control. , 2019, The Journal of infection.

[11]  G. Garcia-Effron,et al.  Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris. , 2019, The Journal of antimicrobial chemotherapy.

[12]  R. Cordeiro,et al.  Cefepime and Amoxicillin Increase Metabolism and Enhance Caspofungin Tolerance of Candida albicans Biofilms , 2019, Front. Microbiol..

[13]  Maneesha K. Suresh,et al.  An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms. , 2019, International journal of medical microbiology : IJMM.

[14]  O. Cornely,et al.  Essentials in Candida bloodstream infection , 2018, Infection.

[15]  E. Abdala,et al.  Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria , 2018, Antimicrobial Agents and Chemotherapy.

[16]  B. Kullberg,et al.  Invasive Candidiasis. , 2019, The New England journal of medicine.

[17]  M. Pujol,et al.  Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia , 2017, Expert opinion on pharmacotherapy.

[18]  Zhìhóng Hú,et al.  Recent Advances in Ergosterol Biosynthesis and Regulation Mechanisms in Saccharomyces cerevisiae , 2017, Indian Journal of Microbiology.

[19]  A. Borman,et al.  Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris , 2017, Emerging infectious diseases.

[20]  J. Meis,et al.  First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. , 2016, The Journal of infection.

[21]  A. Chowdhary,et al.  Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation , 2016, New microbes and new infections.

[22]  M. Shams-Ghahfarokhi,et al.  Cold atmospheric plasma inhibits the growth of Candida albicans by affecting ergosterol biosynthesis and suppresses the fungal virulence factors in vitro. , 2016, Photodiagnosis and photodynamic therapy.

[23]  U. Tatu,et al.  Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris , 2015, BMC Genomics.

[24]  Ning Mao,et al.  Efficacy of Combined Vancomycin and Fosfomycin against Methicillin-Resistant Staphylococcus aureus in Biofilms In Vivo , 2014, PloS one.

[25]  V. Fowler,et al.  Clinical management of Staphylococcus aureus bacteremia: a review. , 2014, JAMA.

[26]  M. Cooper,et al.  Glycopeptide antibiotics: Back to the future , 2014, The Journal of Antibiotics.

[27]  N. Govender,et al.  Candida auris–Associated Candidemia, South Africa , 2014, Emerging infectious diseases.

[28]  Parth Malik,et al.  Relationship of Azole Resistance with the Structural Alteration of the Target Sites: Novel Synthetic Compounds for Better Antifungal Activities , 2014 .

[29]  M. Treiber,et al.  Rifampicin induced virulence determinants increase Candida albicans biofilm formation , 2013 .

[30]  George Y. Liu,et al.  Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model. , 2012, The Journal of antimicrobial chemotherapy.

[31]  Jong-Hee Shin,et al.  First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris , 2011, Journal of Clinical Microbiology.

[32]  M. Treiber,et al.  Rifampicin induces MDR1 expression in Candida albicans. , 2008, The Journal of antimicrobial chemotherapy.

[33]  M. Ghannoum,et al.  Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins , 2002, Antimicrobial Agents and Chemotherapy.

[34]  G. Horgan,et al.  Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR , 2002 .

[35]  M. Ghannoum,et al.  Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces , 2002, Infection and Immunity.

[36]  S. Stepanović,et al.  A modified microtiter-plate test for quantification of staphylococcal biofilm formation. , 2000, Journal of microbiological methods.

[37]  J. Waitz Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .